SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015947
Filing Date
2023-09-22
Accepted
2023-09-22 16:30:21
Documents
13
Period of Report
2023-09-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230919x8k.htm   iXBRL 8-K 36568
  Complete submission text file 0001558370-23-015947.txt   169597

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20230919.xsd EX-101.SCH 3818
3 EX-101.DEF elev-20230919_def.xml EX-101.DEF 2823
4 EX-101.LAB elev-20230919_lab.xml EX-101.LAB 17910
5 EX-101.PRE elev-20230919_pre.xml EX-101.PRE 11887
7 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230919x8k_htm.xml XML 5048
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 231272098
SIC: 2836 Biological Products, (No Diagnostic Substances)